Logo

CVS Caremark

In Prescribing Study, Few Doctors Altered Treatment for Poor Plavix Metabolizers Based on Genotype
Premium

A study led by researchers from Brigham and Women's Hospital on the effect of CYP2C19 testing on physicians' prescribing patterns has found that when doctors received patient test results for genetic markers associated with clopidogrel response through a pharmacy-benefit manager-

Personalized Medicine in 2012: Industry Takes a Wait-and-See Approach Due to Market Unknowns
Premium

Roche made a splash last year with its repeated overtures to acquire genome sequencing firm Illumina, but for the most part, 2012 was a quiet year during which players in the life sciences industry took modest steps to increase their capabilities to advance personalized treatment

Buying Remaining Stake in Generation Health, CVS Caremark Keeps PGx Programs but Cuts Staff
Premium

Originally published Aug. 23.

New Firm MetaDiagnostic Moves in to Help Dx Developers, Payors as PBMs Shift from Personalized Rx
Premium

Originally published Aug. 27.

Following Merger, Express Scripts May Cut Back Medco's Personalized Medicine Programs
Premium

Originally published May 4.
Mar 14, 2012

Does Lack of PGx Link in Recent Studies Foreshadow End of CYP2D6 Genotyping for Tamoxifen?
Premium

Jul 27, 2011

Fate of Medco's Personalized Medicine Programs Uncertain Under Express Scripts' Acquisition Plan
Premium

May 11, 2011

Generation Health Tackles Slow Genetic Test Uptake by Unpacking CPT Codes, Planning Utility Studies
Premium

May 4, 2011

Supreme Court Case on Script Data Sale Presents 'Gray Area' for PBM Personalized Rx Efforts
Premium

Jun 30, 2010

PGXL Joins Generation Health's Best Test Network
Premium

Jun 24, 2010

Generation Health Contracts with PGXL to Offer Pharmacogenetic Tests

Jun 2, 2010

CVS Caremark, Generation Health Unveil 13 Drugs for PGx Testing Program, But Not Warfarin
Premium

Jun 2, 2010

CVS Caremark, Generation Health Select 13 Drugs for PGx Alliance

May 26, 2010

Medco to Expand PGx Offerings to All Clients in July
Premium

Dec 21, 2009

CVS Caremark Expands Investment in Generation Health

Dec 9, 2009

In Comments to GINA Rule, GPPC Tries to Clarify Debate Around 'Underwriting' for Wellness Programs
Premium

Dec 2, 2009

DMAA Requests Moratorium on GINA's 'Underwriting' Restrictions; Personalized Rx Advocates Object
Premium

Nov 11, 2009

CVS Caremark Expanding PGx Testing to Its PBM Customers
Premium

Nov 10, 2009

CVS Caremark, Generation Health to Expand PGx Testing to Millions

Nov 4, 2009

Insurers Tracking Unnecessary Testing with Myriad's BRACAnalysis Tests
Premium

Oct 21, 2009

Generation Health Emulates the PBM Model to Optimize Genetic Testing for Payors
Premium

Breaking News
The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.